RKDA
RKDA
NASDAQ · Food Products

Arcadia Biosciences Inc

$1.33
+0.03 (+2.31%)
As of Mar 31, 5:01 PM ET ·
Financial Highlights (FY 2026)
Revenue
6.49M
Net Income
-9,049,597
Gross Margin
44.3%
Profit Margin
-139.5%
Rev Growth
-9.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 44.3% 44.3% 64.9% 64.9%
Operating Margin -72.3% -65.1% 14.7% 13.5%
Profit Margin -139.5% -132.5% 14.8% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 6.49M 7.16M 1.13M 1.01M
Gross Profit 2.88M 3.17M 731.9K 656.9K
Operating Income -4,690,721 -4,658,628 165.1K 136.9K
Net Income -9,049,597 -8,987,681 167.1K 122.6K
Gross Margin 44.3% 44.3% 64.9% 64.9%
Operating Margin -72.3% -65.1% 14.7% 13.5%
Profit Margin -139.5% -132.5% 14.8% 12.1%
Rev Growth -9.4% -9.4% -3.2% +0.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.55M 1.44M
Total Equity 1.12M 1.03M
D/E Ratio 1.38 1.40
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -4,505,428 -4,723,192 233.2K 200.7K
Free Cash Flow 165.9K 91.6K